Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | FATE |
---|---|---|
09:32 ET | 34993 | 5.3801 |
09:33 ET | 16444 | 5.4027 |
09:35 ET | 16008 | 5.41 |
09:37 ET | 3165 | 5.41 |
09:39 ET | 6005 | 5.485 |
09:42 ET | 5875 | 5.47 |
09:44 ET | 16345 | 5.48 |
09:46 ET | 57646 | 5.48 |
09:48 ET | 17884 | 5.51 |
09:50 ET | 5810 | 5.53 |
09:51 ET | 8949 | 5.5866 |
09:53 ET | 21593 | 5.515 |
09:55 ET | 17447 | 5.55 |
09:57 ET | 8452 | 5.55 |
10:00 ET | 9641 | 5.55 |
10:02 ET | 7866 | 5.565 |
10:04 ET | 9734 | 5.607 |
10:06 ET | 4130 | 5.5915 |
10:08 ET | 13494 | 5.64 |
10:09 ET | 10768 | 5.625 |
10:11 ET | 10414 | 5.625 |
10:13 ET | 20128 | 5.645 |
10:15 ET | 3159 | 5.63 |
10:18 ET | 3725 | 5.6408 |
10:20 ET | 4700 | 5.63 |
10:22 ET | 10422 | 5.62 |
10:24 ET | 9388 | 5.6206 |
10:26 ET | 5200 | 5.6 |
10:27 ET | 5500 | 5.57 |
10:29 ET | 14888 | 5.6 |
10:31 ET | 5383 | 5.6199 |
10:33 ET | 7542 | 5.62 |
10:36 ET | 18442 | 5.65 |
10:38 ET | 11563 | 5.67 |
10:40 ET | 33864 | 5.7 |
10:42 ET | 6260 | 5.69 |
10:44 ET | 5226 | 5.695 |
10:45 ET | 4398 | 5.642 |
10:47 ET | 5320 | 5.61 |
10:49 ET | 7663 | 5.615 |
10:51 ET | 5332 | 5.615 |
10:54 ET | 9194 | 5.61 |
10:56 ET | 8218 | 5.655 |
10:58 ET | 9499 | 5.65 |
11:00 ET | 2998 | 5.64 |
11:02 ET | 2500 | 5.68 |
11:03 ET | 2833 | 5.685 |
11:05 ET | 7060 | 5.67 |
11:07 ET | 1983 | 5.65 |
11:09 ET | 11015 | 5.625 |
11:12 ET | 12304 | 5.58 |
11:14 ET | 5700 | 5.59 |
11:16 ET | 5578 | 5.6 |
11:18 ET | 3503 | 5.6085 |
11:20 ET | 3635 | 5.61 |
11:21 ET | 12351 | 5.62 |
11:23 ET | 2450 | 5.63 |
11:25 ET | 5875 | 5.63 |
11:27 ET | 2800 | 5.635 |
11:30 ET | 1400 | 5.65 |
11:32 ET | 5674 | 5.685 |
11:34 ET | 12281 | 5.67 |
11:36 ET | 12470 | 5.6899 |
11:38 ET | 14128 | 5.665 |
11:39 ET | 6410 | 5.635 |
11:41 ET | 3216 | 5.63 |
11:43 ET | 7630 | 5.665 |
11:45 ET | 400 | 5.67 |
11:48 ET | 8599 | 5.6911 |
11:50 ET | 7072 | 5.69 |
11:52 ET | 8128 | 5.7 |
11:54 ET | 11003 | 5.715 |
11:56 ET | 10851 | 5.71 |
11:57 ET | 7231 | 5.72 |
11:59 ET | 15292 | 5.73 |
12:01 ET | 12393 | 5.75 |
12:03 ET | 1421 | 5.7514 |
12:06 ET | 8437 | 5.73 |
12:08 ET | 8772 | 5.755 |
12:10 ET | 6302 | 5.755 |
12:12 ET | 18379 | 5.72 |
12:14 ET | 3116 | 5.75 |
12:15 ET | 3119 | 5.765 |
12:17 ET | 7312 | 5.765 |
12:19 ET | 2460 | 5.775 |
12:21 ET | 9614 | 5.7689 |
12:24 ET | 8214 | 5.76 |
12:26 ET | 4672 | 5.755 |
12:28 ET | 2258 | 5.73 |
12:30 ET | 2920 | 5.76 |
12:32 ET | 12073 | 5.785 |
12:33 ET | 10830 | 5.78 |
12:35 ET | 3958 | 5.775 |
12:37 ET | 3295 | 5.775 |
12:39 ET | 4909 | 5.765 |
12:42 ET | 5662 | 5.76 |
12:44 ET | 4613 | 5.765 |
12:46 ET | 4167 | 5.76 |
12:48 ET | 7127 | 5.755 |
12:50 ET | 6157 | 5.745 |
12:51 ET | 3351 | 5.7453 |
12:53 ET | 5261 | 5.7354 |
12:55 ET | 12233 | 5.755 |
12:57 ET | 12001 | 5.73 |
01:00 ET | 2377 | 5.73 |
01:02 ET | 5004 | 5.725 |
01:04 ET | 13893 | 5.75 |
01:06 ET | 680 | 5.7499 |
01:08 ET | 800 | 5.745 |
01:09 ET | 4658 | 5.735 |
01:11 ET | 6072 | 5.73 |
01:13 ET | 13008 | 5.75 |
01:15 ET | 10741 | 5.75 |
01:18 ET | 10927 | 5.75 |
01:20 ET | 2471 | 5.745 |
01:22 ET | 3358 | 5.75 |
01:24 ET | 4647 | 5.75 |
01:26 ET | 4554 | 5.7418 |
01:27 ET | 5085 | 5.75 |
01:29 ET | 5887 | 5.755 |
01:31 ET | 3394 | 5.755 |
01:33 ET | 6160 | 5.75 |
01:36 ET | 1450 | 5.745 |
01:38 ET | 1900 | 5.745 |
01:40 ET | 6211 | 5.74 |
01:42 ET | 14596 | 5.7315 |
01:44 ET | 100 | 5.74 |
01:45 ET | 5649 | 5.73 |
01:47 ET | 16492 | 5.74 |
01:49 ET | 4944 | 5.745 |
01:51 ET | 5613 | 5.72 |
01:54 ET | 5152 | 5.72 |
01:56 ET | 10655 | 5.74 |
01:58 ET | 3919 | 5.7442 |
02:00 ET | 12666 | 5.74 |
02:02 ET | 10529 | 5.74 |
02:03 ET | 2951 | 5.735 |
02:05 ET | 2769 | 5.735 |
02:07 ET | 3569 | 5.735 |
02:09 ET | 1982 | 5.735 |
02:12 ET | 13343 | 5.705 |
02:14 ET | 3635 | 5.7 |
02:16 ET | 5907 | 5.7192 |
02:18 ET | 5601 | 5.72 |
02:20 ET | 2104 | 5.73 |
02:21 ET | 6290 | 5.7407 |
02:23 ET | 11517 | 5.7407 |
02:25 ET | 1245 | 5.745 |
02:27 ET | 3800 | 5.74 |
02:30 ET | 20069 | 5.74 |
02:32 ET | 17176 | 5.74 |
02:34 ET | 10568 | 5.745 |
02:36 ET | 2000 | 5.75 |
02:38 ET | 5602 | 5.72 |
02:39 ET | 7725 | 5.72 |
02:41 ET | 5618 | 5.715 |
02:43 ET | 4394 | 5.72 |
02:45 ET | 28520 | 5.745 |
02:48 ET | 35473 | 5.78 |
02:50 ET | 14506 | 5.795 |
02:52 ET | 12505 | 5.81 |
02:54 ET | 38100 | 5.81 |
02:56 ET | 25507 | 5.8261 |
02:57 ET | 10049 | 5.835 |
02:59 ET | 3763 | 5.835 |
03:01 ET | 1350 | 5.832 |
03:03 ET | 9147 | 5.84 |
03:06 ET | 17803 | 5.8442 |
03:08 ET | 15318 | 5.88 |
03:10 ET | 5396 | 5.88 |
03:12 ET | 10831 | 5.87 |
03:14 ET | 18125 | 5.855 |
03:15 ET | 14310 | 5.835 |
03:17 ET | 9943 | 5.825 |
03:19 ET | 44061 | 5.86 |
03:21 ET | 18697 | 5.885 |
03:24 ET | 11480 | 5.905 |
03:26 ET | 14237 | 5.885 |
03:28 ET | 11872 | 5.875 |
03:30 ET | 8363 | 5.885 |
03:32 ET | 11800 | 5.885 |
03:33 ET | 58119 | 5.94 |
03:35 ET | 8420 | 5.93 |
03:37 ET | 21470 | 5.935 |
03:39 ET | 9150 | 5.915 |
03:42 ET | 14812 | 5.94 |
03:44 ET | 19828 | 5.95 |
03:46 ET | 25710 | 5.9699 |
03:48 ET | 11103 | 5.99 |
03:50 ET | 38488 | 5.955 |
03:51 ET | 37393 | 6.005 |
03:53 ET | 42589 | 6 |
03:55 ET | 76184 | 5.96 |
03:57 ET | 33685 | 5.9585 |
04:00 ET | 402092 | 5.92 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Fate Therapeutics Inc | 575.2M | -1.9x | --- |
Tango Therapeutics Inc | 575.8M | -5.7x | --- |
2Seventy Bio Inc | 502.4M | -1.4x | --- |
Nurix Therapeutics Inc | 583.7M | -3.3x | --- |
Sorrento Therapeutics Inc | 476.6M | -0.8x | --- |
Merus NV | 683.0M | -10.2x | --- |
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of programmed cellular immunotherapies for patients with cancer. It uses human induced pluripotent stem cells (iPSCs) generated from its proprietary iPSC product platform to create genetically engineered, clonal master iPSC lines having preferred biological properties. The Company is advancing a pipeline of programmed cellular immunotherapies, including off-the-shelf natural killer (NK) and T-cell product candidates derived from clonal master iPSC lines for the treatment of cancer. The Company's product pipeline includes FT596, FT538, FT576, FT536, FT573, FT819, FT500 and FT516. FT516 is an investigational off-the-shelf NK cell cancer immunotherapy derived from a clonal master iPSC line engineered to express a novel CD16 (hnCD16) Fc receptor. FT596 is an investigational off-the-shelf CAR NK cell cancer immunotherapy derived from a clonal engineered master iPSC line.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $575.2M |
---|---|
Revenue (TTM) | $69.0M |
Shares Outstanding | 97.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.47 |
EPS | $-3.05 |
Book Value | $7.09 |
P/E Ratio | -1.9x |
Price/Sales (TTM) | 8.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -454.04% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.